FUFRX | RYUTX | FUFRX / RYUTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 20 years | - |
Gain YTD | 30.431 | 23.403 | 130% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.69B | 42.1M | 15,881% |
Annual Yield % from dividends | 2.62 | 3.38 | 77% |
Returns for 1 year | 30.24 | 28.25 | 107% |
Returns for 3 years | 23.61 | 24.25 | 97% |
Returns for 5 years | 24.06 | 31.34 | 77% |
Returns for 10 years | 58.15 | 71.57 | 81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRULX | 17.78 | N/A | N/A |
MFS Blended Research Value Equity R3 | |||
GARKX | 9.79 | N/A | N/A |
Goldman Sachs Global Rl Estt Secs C | |||
FMQSX | 14.59 | -0.02 | -0.14% |
Franklin Mutual Quest R | |||
MGIBX | 37.37 | -0.33 | -0.88% |
MFS International Intrinsic Value B | |||
FBTDX | 133.88 | -1.84 | -1.36% |
Franklin Biotechnology Discovery C |